Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort

被引:9
作者
Clausen, Louise Nygaard [1 ,2 ,3 ]
Weis, Nina
Schonning, Kristian [4 ]
Fenger, Mogens [5 ]
Krarup, Henrik [6 ,7 ]
Bukh, Jens [1 ,2 ,3 ]
Benfield, Thomas [2 ]
机构
[1] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen Hepatitis Program CO HEP C, DK-2650 Hvidovre, Denmark
[2] Copenhagen Univ Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark
[3] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark
[5] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark
[6] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Biochem, Aarhus, Denmark
[7] Aarhus Univ Hosp, Aalborg Hosp, Dept Med Gastroenterol, Aarhus, Denmark
基金
英国医学研究理事会;
关键词
Hepatitis C virus; HIV; hepatitis B virus; spontaneous HCV clearance; route of transmission; HIV-INFECTED PATIENTS; INJECTION-DRUG USERS; VIRAL LOAD; RECOVERED CHIMPANZEES; HCV; RESPONSES; REPLICATION; RECHALLENGE; PREVALENCE;
D O I
10.3109/00365548.2011.589077
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Around a quarter of individuals infected with hepatitis C virus (HCV) are spontaneously able to clear the virus. Correlates of spontaneous HCV clearance are not well established and the aim of this study was to characterize factors associated with spontaneous HCV clearance in a human immunodeficiency virus (HIV)-co-infected cohort. Methods: We analyzed 327 anti-HCV-positive HIV-1-infected patients using multivariate logistic regression. HCV clearance was defined as the presence of anti-HCV with undetectable HCV RNA from at least 2 measurements more than 6 months apart. Results: We included 327 HIV-1-infected individuals, predominantly of Caucasian race; 112 (34%) were females, 258 (79%) were injecting drug users (IDU), 25 (8%) were men who have sex with men (MSM), and 20 (6%) were hepatitis B surface antigen (HBsAg)-positive. Seventy-six (23%; 95% confidence interval (CI) 18-28) had cleared their HCV infection and 251 (77%; 95% CI 72-82) had a chronic infection. The clearance rate in HBsAg-positive individuals was 65%. Being female, HBsAg-positive, or belonging to HIV exposure groups IDU and MSM predicted higher HCV clearance rates (adjusted odds ratio (aOR) 1.8, 95% CI 1-3.2; aOR 7.6, 95% CI 2.7-21; aOR 5.2, 1.2-23.5; and aOR 10.2, 95% CI 1.8-58, respectively). Race, acquired immunodeficiency syndrome (AIDS), and antiretroviral therapy were not associated with HCV clearance. Conclusions: The HCV clearance rate in this HIV-1 cohort was 23%. MSM and IDUs may have higher clearance rates due to their repeated exposure to low-dose HCV, leading to immune memory. Our data suggest an interaction of hepatitis B virus and HCV that influences the outcome of acute HCV infection.
引用
收藏
页码:798 / 803
页数:6
相关论文
共 50 条
  • [21] Can Persistent Infections with Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, and Human T Lymphotropic Virus Type 1 Be Eradicated?
    Teixeira, Sandy Vieira
    Prates, Gabriela
    Fonseca, Luiz Augusto Marcondes
    Casseb, Jorge
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (03) : 127 - 133
  • [22] Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment (vol 12, 780887, 2022)
    Shahriar, Sagarika
    Araf, Yusha
    Ahmad, Rasel
    Kattel, Pravakar
    Sah, Ganga Sagar
    Rahaman, Tanjim Ishraq
    Sadiea, Rahila Zannat
    Sultana, Shahnaj
    Islam, Md. Sayeedul
    Zheng, Chunfu
    Hossain, Md. Golzar
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [23] Prevalence and Correlates of Co-infection with Human Immunodeficiency Virus and Hepatitis C Virus in Male Injection Drug Users in Iran
    Hosseini, Mostafa
    SeyedAlinaghi, SeyedAhmad
    Kheirandish, Parastoo
    Javid, GholamReza Esmaeli
    Shirzad, Hadi
    Karami, Nazli
    Jahani, MohammadReza
    Ahmadian, MohammadReza Seyed
    Payvarmehr, Fatemeh
    Mohraz, Minoo
    Koochak, Hamid Emadi
    McFarland, Willi
    ARCHIVES OF IRANIAN MEDICINE, 2010, 13 (04) : 318 - 323
  • [24] Seroprevelance of Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus in Northern Cyprus
    Guler, Emrah
    Suer, Kaya
    Arikan, Ayse
    Guvenir, Meryem
    Sanlidag, Tamer
    MEDICAL JOURNAL OF BAKIRKOY, 2018, 14 (04) : 332 - 338
  • [25] Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors
    Flichman, Diego M.
    Blejer, Jorgelina L.
    Livellara, Beatriz I.
    Re, Viviana E.
    Bartoli, Sonia
    Bustos, Juan A.
    Ansola, Claudia P.
    Hidalgo, Susana
    Cerda, Martin E.
    Levin, Alicia E.
    Huenul, Adriana
    Riboldi, Victoria
    Trevino, Elena M. C.
    Salamone, Horacio J.
    Nunez, Felix A.
    Fernandez, Robert J.
    Reybaud, Juan F.
    Campos, Rodolfo H.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [26] Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors
    Diego M Flichman
    Jorgelina L Blejer
    Beatriz I Livellara
    Viviana E Re
    Sonia Bartoli
    Juan A Bustos
    Claudia P Ansola
    Susana Hidalgo
    Martin E Cerda
    Alicia E Levin
    Adriana Huenul
    Victoria Riboldi
    Elena MC Treviño
    Horacio J Salamone
    Felix A Nuñez
    Robert J Fernández
    Juan F Reybaud
    Rodolfo H Campos
    BMC Infectious Diseases, 14
  • [27] In vitro basal T-cell proliferation among asymptomatic Human T cell Leukemia Virus type 1 patients co-infected with hepatitis C and/or Human Immunodeficiency Virus type 1
    Assone, Tatiane
    Kanashiro, Tatiana M.
    Baldassin, Maira P. M.
    Paiva, Arthur
    Haziot, Michel E.
    Smid, Jerusa
    de Oliveira, Augusto Penalva
    Fonseca, Luiz Augusto M.
    Norris, Philip J.
    Casseb, Jorge
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (02) : 106 - 112
  • [28] The role of human T cell lymphotrophic virus type 1, hepatitis B virus and hepatitis C virus coinfections in leprosy
    Lima Machado, Paulo Roberto
    Johnson, Warren D.
    Glesby, Marshall J.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2012, 107 : 43 - 48
  • [29] Implications of Hepatitis B and C on the Human Immunodeficiency Virus Infections
    Yildirim, Figen Sarigul
    Sayan, Murat
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2022, 28 (02): : 72 - 78
  • [30] Human immunodeficiency virus and hepatitis C virus coinfection
    Cacoub, P.
    Sene, D.
    Rosenthal, E.
    Pol, S.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (03): : S82 - S89